Response to advances statistical methods and designs for clinical trials for COVID-19.
作者信息
Gautret Philippe, Hoang Van Thuan, Lagier Jean-Christophe, Raoult Didier
机构信息
IHU-Méditerranée Infection, Marseille, France.; Aix Marseille Univ, IRD, AP-HM, SSA, VITROME, Marseille, France.
IHU-Méditerranée Infection, Marseille, France.; Aix Marseille Univ, IRD, AP-HM, SSA, VITROME, Marseille, France; Thai Binh University of Medicine and Pharmacy, Thai Binh, Vietnam.
出版信息
Int J Antimicrob Agents. 2021 Jan;57(1):106235. doi: 10.1016/j.ijantimicag.2020.106235.
Abstract
摘要
相似文献
1
Response to advances statistical methods and designs for clinical trials for COVID-19.对COVID-19临床试验先进统计方法和设计的回应。
Int J Antimicrob Agents. 2021 Jan;57(1):106235. doi: 10.1016/j.ijantimicag.2020.106235.
2
Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.CEPI/BC 2020 年 3 月 12-13 日会议共识总结报告：评估 COVID-19 疫苗引起疾病增强的风险。
Vaccine. 2020 Jun 26;38(31):4783-4791. doi: 10.1016/j.vaccine.2020.05.064. Epub 2020 May 25.
3
Detectable Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Human Breast Milk of a Mildly Symptomatic Patient With Coronavirus Disease 2019 (COVID-19).检测到轻度症状的 2019 冠状病毒病（COVID-19）患者的人乳中存在可检测的严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）。
Clin Infect Dis. 2021 Jan 23;72(1):128-130. doi: 10.1093/cid/ciaa673.
4
A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients.用于测量 COVID-19 患者体内 SARS-CoV-2 特异性反应的全血检测。
Clin Microbiol Infect. 2021 Feb;27(2):286.e7-286.e13. doi: 10.1016/j.cmi.2020.09.051. Epub 2020 Oct 10.
5
Ebselen, a new candidate therapeutic against SARS-CoV-2.依布硒啉，一种新型抗SARS-CoV-2的候选治疗药物。
Int J Surg. 2020 Dec;84:53-56. doi: 10.1016/j.ijsu.2020.10.018. Epub 2020 Oct 23.
6
Symptoms and immunoglobulin development in hospital staff exposed to a SARS-CoV-2 outbreak.接触 SARS-CoV-2 疫情的医院工作人员的症状和免疫球蛋白发展情况。
Pediatr Allergy Immunol. 2020 Oct;31(7):841-847. doi: 10.1111/pai.13278. Epub 2020 Jun 18.
7
Principles and new perspectives in the vaccination against SARS-CoV-2 virus.SARS-CoV-2 病毒疫苗接种的原则和新视角。
Cas Lek Cesk. 2020 Winter;159(7-8):298-302.
8
SARS-CoV-2/COVID-19, Lymphatic vessels, lymph, and lymphology.严重急性呼吸综合征冠状病毒2型/冠状病毒病、淋巴管、淋巴液与淋巴学
Lymphology. 2020;53(3):97-98.
9
SARS-CoV-2 viremia may predict rapid deterioration of COVID-19 patients.SARS-CoV-2 病毒血症可能预示着 COVID-19 患者病情迅速恶化。
Braz J Infect Dis. 2020 Nov-Dec;24(6):565-569. doi: 10.1016/j.bjid.2020.08.010. Epub 2020 Sep 15.
10
SARS-CoV-2 and its relationship with the genitourinary tract: Implications for male reproductive health in the context of COVID-19 pandemic.SARS-CoV-2 及其与泌尿生殖系统的关系：COVID-19 大流行背景下对男性生殖健康的影响。
Andrology. 2021 Jan;9(1):73-79. doi: 10.1111/andr.12896. Epub 2020 Sep 30.
引用本文的文献
1
Effect of hydroxychloroquine and azithromycin on the viral clearance of SARS-CoV-2: response to Hervé Seligmann.羟氯喹和阿奇霉素对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）病毒清除的影响：对埃尔韦·塞利格曼的回应
Int J Antimicrob Agents. 2021 Mar;57(3):106306. doi: 10.1016/j.ijantimicag.2021.106306. Epub 2021 Feb 14.
本文引用的文献
1
Referring to the study: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial.参考研究：《羟氯喹和阿奇霉素治疗新型冠状病毒肺炎：一项开放标签非随机临床试验的结果》
Int J Antimicrob Agents. 2021 Jan;57(1):106176. doi: 10.1016/j.ijantimicag.2020.106176.
Zotero 插件